Article info

Download PDFPDF

PA-153
SAFETY OF RVSV EBOLA VACCINE, AFTER 6 MONTHS FOLLOW-UP, IN ADULTS: A PHASE 1 TRIAL CONDUCTED IN LAMBARÉNÉ, GABON

Authors

  • José Fernandes Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon Institute for Tropical Medicine, University of Tübingen (Germany) Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Emmanuel B. Bache Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon PubMed articlesGoogle scholar articles
  • Régis M Obiang Mba Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon PubMed articlesGoogle scholar articles
  • Anita L. Kabwende Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon PubMed articlesGoogle scholar articles
  • Benjamin Mordmüller Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon Institute for Tropical Medicine, University of Tübingen (Germany) PubMed articlesGoogle scholar articles
  • Sanjeev Krishna Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon Institute for Tropical Medicine, University of Tübingen (Germany) Institute for Infection and Immunity, St. George's, University of London, UK PubMed articlesGoogle scholar articles
  • Peter G. Kremsner Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon Institute for Tropical Medicine, University of Tübingen (Germany) PubMed articlesGoogle scholar articles
  • Martin P. Grobusch Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon Institute for Tropical Medicine, University of Tübingen (Germany) Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Agnandji Selidji Todagbe Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon Institute for Tropical Medicine, University of Tübingen (Germany) PubMed articlesGoogle scholar articles

Citation

Fernandes J, Bache EB, Mba RMO, et al
SAFETY OF RVSV EBOLA VACCINE, AFTER 6 MONTHS FOLLOW-UP, IN ADULTS: A PHASE 1 TRIAL CONDUCTED IN LAMBARÉNÉ, GABON

Publication history

  • First published February 12, 2017.
Online issue publication 
March 08, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.